Group 1 - The stock price of Jinkai Biotechnology closed at 39.04 yuan on August 13, 2025, reflecting an increase of 1.51% from the previous trading day [1] - The trading volume on that day was 55,624 hands, with a total transaction amount of 216 million yuan [1] - Jinkai Biotechnology focuses on the small molecule CDMO sector, with its main business encompassing the research, production, and sales of pharmaceutical intermediates and active pharmaceutical ingredients [1] Group 2 - The company emphasizes technological innovation as its core driving force and continues to deepen its engagement in the small molecule CDMO field [1] - In response to investor inquiries, the company stated it would carefully evaluate and advance measures that enhance long-term value, considering its development strategy, industry trends, and actual operating conditions [1] - On August 13, the net inflow of main funds was 9.1001 million yuan, accounting for 0.41% of the circulating market value, while the cumulative net outflow over the past five trading days was 42.4359 million yuan [1]